Optometry Times® news summary 1/17/2021

Ahead of Veterans Day, Paul Barney, OD, urges optometrists to watch for combat- and trauma-related eye injuries in veterans.

Through Tenpoint Therapeutics’ new telehealth program, eligible adults with presbyopia can receive Yuvezzi at home.

The agency concluded that GLP-1 receptor agonists carry a potential increased risk of the rare optic neuropathy and is adding it to the Warnings and Precautions section of every product's label.

More consumers spent $100 to $199 on eyewear in Q3 2026, and managed vision care coverage reached a 5-quarter high of 72%.

As artificial intelligence advances, so do VR devices.

A wet AMD biosimilar approval leads this week’s recap, plus Medicare pay updates and tips to avoid burnout and losing patients.

MyoSpectrumNet pulls 3 public fundus datasets into 1 multi-output framework. Screening and grading accuracy held up against dedicated models.

ODs face a $32.63 Medicare conversion factor in 2027, plus 80% payment for the lower-cost service when an E/M visit and 0-day procedure share a date.